Sigrun Halvorsen

Showing 1-3 of 3 articles

EAPCI Position Statement on Invasive Management of Acute Coronary Syndromes during the COVID-19 pandemic

Chieffo A, Stefanini G, Price S, Barbato E, Tarantini G, Karam N, Moreno R, Buchanan G, Gilard M, Halvorsen S, Huber K, James S, Neumann F, Möllmann H, Roffi M, Tavazzi G, Ferré J, Windecker S, Dudek D, Baumbach A

May 14, 2020 | 10.4244/EIJY20M05_01

Myocardial perfusion grade predicts final infarct size and left ventricular function in patients with ST-elevation myocardial infarction treated with a pharmaco-invasive strategy (thrombolysis and early angioplasty)

Bethke A, Halvorsen S, Bohmer E, Abdelnoor M, Arnesen H, Hoffmann P

September 22, 2015 | 10.4244/EIJY15M04_02

STEMI treatment in areas remote from primary PCI centres

August 25, 2012 | 10.4244/EIJV8SPA8

1

Latest news

LM revascularisation, annulus rupture, risk stratification, renal denervation

Ahead of print: The Impact of COVID-19 on Interventional Cardiology Practice: Results of the EAPCI Survey

Marco Roffi, Dariusz Dudek, et al.

A perspective from EAPCI Women and Women as One

Gill Louise Buchanan

Last Update: CULPRIT, NOBEL, IVUS-XPL, SAFARI-STEMI

(supported by Biotronik)

Guidance Papers

Guidelines, consensus & position papers

EuroIntervention new Editorial Board

This week’s JAA’s: Paradigm Study: 12months outcome, GLASSY ACS vs SIHD...

Coronary

Valvular disease

Heart failure

Peripheral

Hypertension

Stroke